Citadel Advisors »

Fibrobiologics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $115k 211k 0.55
2025-06-30 $145k 233k 0.62
2025-03-31 $43k 48k 0.90

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Fibrobiologics

Vanguard Group
Yorkville Advisors Global
Millennium Management
BlackRock
Landscape Capital Management
Gts Securities
Cascade Financial Partners
Geode Capital Management
Citadel Advisors
HPM Partners
State Street Corporation
Optivise Advisory Services
Requisite Capital Management
Wiley Bros.-aintree Capital
American Institute for Advanced Investment Management

View all funds holding Fibrobiologics